Birbal Singh

Prof. Birbal Singh

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2012 in Experimental Diabetes Research
Verified
Journal Article
Open access
PDF file
MKManoj Kumar
Manoj Kumar
RNRavinder Nagpal
Ravinder Nagpal
RKRajesh Kumar
Rajesh Kumar
RHR. Hemalatha
R. Hemalatha
VVVinod Verma
Vinod Verma
HYHariom Yadav
Hariom Yadav
Cardiovascular diseases are one of the major causes of deaths in adults in the western world. Elevated levels of certain blood lipids have been reported to be the principal cause of cardiovascular disease and other disabilities in developed countries. Several animal and clinical trials have shown a positive association between cholesterol levels and the risks of coronary heart disease. Current dietary strategies for the prevention of cardiovascular disease advocate adherence to low-fat/low-saturated-fat diets. Although there is no doubt that, in experimental conditions, low-fat diets offer an effective means of reducing blood cholesterol concentrations on a population basis, these appear to be less effective, largely due to poor compliance, attributed to low palatability and acceptability of these diets to the consumers. Due to the low consumer compliance, attempts have been made to identify other dietary components that can reduce blood cholesterol levels. Supplementation of diet with fermented dairy products or lactic acid bacteria containing dairy products has shown the potential to reduce serum cholesterol levels. Various approaches have been used to alleviate this issue, including the use of probiotics, especiallyBifidobacteriumspp. andLactobacillusspp.. Probiotics, the living microorganisms that confer health benefits on the host when administered in adequate amounts, have received much attention on their proclaimed health benefits which include improvement in lactose intolerance, increase in natural resistance to infectious disease in gastrointestinal tract, suppression of cancer, antidiabetic, reduction in serum cholesterol level, and improved digestion. In addition, there are numerous reports on cholesterol removal ability of probiotics and their hypocholesterolemic effects. Several possible mechanisms for cholesterol removal by probiotics are assimilation of cholesterol by growing cells, binding of cholesterol to cellular surface, incorporation of cholesterol into the cellular membrane, deconjugation of bile via bile salt hydrolase, coprecipitation of cholesterol with deconjugated bile, binding action of bile by fibre, and production of short-chain fatty acids by oligosaccharides. The present paper reviews the mechanisms of action of anti-cholesterolemic potential of probiotic microorganisms and probiotic food products, with the aim of lowering the risks of cardiovascular and coronary heart diseases.

14 August 2003 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
BSBirbal Singh
Birbal Singh
TBTej K. Bhat
Tej K. Bhat
BSBhupinder Singh
Bhupinder Singh

9 November 2012 in Nutrition Reviews
Verified
Journal Article
Closed access
PDF file
MKMANOJ KUMAR
MANOJ KUMAR
RNRavinder Nagpal
Ravinder Nagpal
VVVinod Verma
Vinod Verma
AKAshok Kumar
Ashok Kumar
NKNavrinder Kaur
Navrinder Kaur
BSBirbal Singh
Birbal Singh

1 August 2017 in Trends in Biotechnology
Verified
Journal Article
Closed access
BSBirbal Singh
Birbal Singh
GMGorakh Mal
Gorakh Mal
FMFrancesco Marotta
Francesco Marotta

1 March 2013 in Nutrition
Verified
Journal Article
Closed access
MKMANOJ KUMAR
MANOJ KUMAR
SRShruti Rakesh
Shruti Rakesh
RNRavinder Nagpal
Ravinder Nagpal
RHR. Hemalatha
R. Hemalatha
ARA. Ramakrishna
A. Ramakrishna
RKRajesh Kumar
Rajesh Kumar

5 August 2011 in British Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
MKMANOJ KUMAR
MANOJ KUMAR
VVV. Verma
V. Verma
RNRavinder Nagpal
Ravinder Nagpal
AKA. Kumar
A. Kumar
PBP. V. Behare
P. V. Behare
PAP. K. Aggarwal
P. K. Aggarwal
The present investigation was carried out to evaluate the hepatoprotective effect of probiotic fermented milk (FM) containingLactobacillus rhamnosusGG andLactobacillus caseistrain Shirota, alone as well as in combination with chlorophyllin (CHL) as an antioxidant agent in male Wistar rats administered aflatoxin-B1(AFB1). AFB1was injected intraperitoneally at the rate of 450 μg/kg body weight per animal twice a week for 6 weeks, maintaining an equal time interval between the two consecutive AFB1administrations. A total of 125 male Wistar rats were randomly allocated to five groups, each group having twenty-five animals. Group I was offered FM containingL. rhamnosusGG andL. caseistrain Shirota. Group II was administered AFB1and served as the control group; group III was administered FM-AFB1, in which besides administering AFB1, FM was also offered. Group IV was offered CHL and AFB1, and group V was offered both FM and CHL along with AFB1. The rats were euthanised at the 15th and 25th week of the experiment and examined for the biochemical and hepatopathological profile. A significant reduction in thiobarbituric acid-reactive substances (TBARS) was observed in the FM–CHL–AFB1group compared with the AFB1control group. FM alone or in combination with CHL was found to show a significant (P < 0·05) hepatoprotective effect by lowering the levels of TBARS and by enhancing the activities of antioxidant enzymes such as glutathione peroxidase, superoxide dismutase, catalase and glutathione-S-transferase, indicating that probiotic FM alone or in combination with CHL possesses a potent protective effect against AFB1-induced hepatic damage.